The discovery and development of boceprevir

Keyphrases

• Boceprevir 100%
• Sustained Viral Response 40%
• NS2B-NS3 Protease 40%
• Virus 20%
• Orally Bioavailable 20%
• Hepatitis C Virus Infection 20%
• Drug Discovery 20%
• Chronic Disease 20%
• Expert Opinion 20%
• Drug Development 20%
• Genotype 1 20%
• In Vivo Efficacy 20%
• Development Effort 20%
• Peginterferon 20%
• Direct-acting Agents 20%
• Completion of Therapy 20%
• Anti-HCV Agents 20%
• Direct-acting 20%
• HCV RNA Levels 20%
• Peptidomimetics 20%
• Molecular Targets 20%
• Ribavirin 20%
• Anemia 20%
• Novel Therapeutics 20%
• Area Cover 20%
• Viral Enzymes 20%
• Neutropenia 20%
• Compound Optimization 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Boceprevir 100%
• Proteinase 40%
• Hepatitis C 20%
• Drug Discovery 20%
• Clinical Study 20%
• Chronic Disease 20%
• Ribavirin 20%
• Drug Development 20%
• Peginterferon 20%
• Anemia 20%
• Neutropenia 20%
• Molecular Target 20%
• Peptidomimetics 20%